Ariadne Technology Licensed by Takeda for Evaluation of Potential Antibody Targets
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Ariadne announces that Takeda San Francisco, Takeda's global center for excellence for biologics, has signed an agreement to license Ariadne's Pathway Studio® software. Takeda plans to utilize the software and underlying text-mining algorithms in their discovery program against cancer, inflammatory and metabolic diseases.
"We are pleased to add Takeda to our already distinguished list of clients", says Gabriella Armin, Director of Marketing for Ariadne. "Our solutions for the pharmaceutical discovery pipeline are proven and we believe this research can enable the ongoing development of novel product candidates for therapeutic use."
"We are pleased to add Takeda to our already distinguished list of clients", says Gabriella Armin, Director of Marketing for Ariadne. "Our solutions for the pharmaceutical discovery pipeline are proven and we believe this research can enable the ongoing development of novel product candidates for therapeutic use."
